CymitQuimica logo

CAS 1797881-48-1

:

Bendamustine Impurity 8

Description:
Bendamustine Impurity 8, identified by its CAS number 1797881-48-1, is a chemical compound associated with the synthesis of the anticancer drug bendamustine. As an impurity, it may arise during the manufacturing process and can affect the purity and efficacy of the final pharmaceutical product. The compound is characterized by its molecular structure, which typically includes functional groups that may influence its reactivity and stability. Impurities like Bendamustine Impurity 8 are often analyzed for their potential impact on drug safety and effectiveness, necessitating rigorous quality control measures in pharmaceutical development. The presence of such impurities can also provide insights into the synthetic pathways and mechanisms involved in drug production. Understanding the characteristics of impurities is crucial for regulatory compliance and ensuring the therapeutic integrity of the drug formulation. Overall, while specific physical and chemical properties may vary, the focus remains on its role in the context of pharmaceutical chemistry and quality assurance.
Formula:C14H19Cl2N3O2
Synonyms:
  • Bendamustine Impurity 8
  • 4-(5-((2-chloroethyl)amino)-1-methyl
  • Bendamustine Impurity 23 HCl (Bendamustine N-Alkylated Impurity HCl)
  • Bendamustine Impurity 23 HCl
  • Deschloroethyl Bendamustine HCl/4-(5-((2-chloroethyl)amino)-1-methyl-1H-benzo[d]imidazol-2-yl)butanoic acid hydrochloride
  • Bendamustine impurity 26/Bendamustine N-Alkylated Impurity HCl/
  • Bendamustine USP Related Compound D
Sort by
The purity filter is not visible because current products do not have associated purity data for filtering.
Found 4 products.